Henry O. Gosebruch, Chief Strategy Officer at AbbVie Inc. (ABBV), sold 34,350 shares at $89.38 ($3.1M) on 2017-10-30, disclosed to the SEC on 2017-10-31.
Open-market sale of $3.1M ABBV by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.38 | 2,150 | $192K | 6.2% |
| 2 | $90.49 | 11,568 | $1.0M | 33.6% |
| 3 | $90.49 | 11,568 | $1.0M | 33.6% |
| 4 | $91.22 | 4,482 | $409K | 13.1% |
| 5 | $91.22 | 4,482 | $409K | 13.1% |
| 6 | $92.02 | 100 |
| $9K |
| 0.3% |
| Total | $90.62 avg | 34,350 | $3.1M | 100% |
| Filing → |
| ABBV | SELL | 2022-05-20 | $13.0M | — | Filing → |
| ABBV | SELL | 2022-03-02 | $6.8M | — | Filing → |
| ABBV | SELL | 2022-03-01 | $2.2M | — | Filing → |